{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T08:46:41Z","timestamp":1759826801405,"version":"3.40.4"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T00:00:00Z","timestamp":1611273600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Zhejiang Province Public Welfare Technology Application Research Projec","award":["2019RC095"],"award-info":[{"award-number":["2019RC095"]}]},{"DOI":"10.13039\/501100010248","name":"Zhejiang Province Public Welfare Technology Application Research Project","doi-asserted-by":"crossref","award":["2018KY241"],"award-info":[{"award-number":["2018KY241"]}],"id":[{"id":"10.13039\/501100010248","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100010248","name":"Zhejiang Province Public Welfare Technology Application Research Project","doi-asserted-by":"crossref","award":["2018KY014"],"award-info":[{"award-number":["2018KY014"]}],"id":[{"id":"10.13039\/501100010248","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Unlike Western countries, there are still few clinical immunology specialists in China, and the optimal care for secondary immunodeficiency caused by hematological malignancies is unknown. Therefore, we initiated this clinician survey study to describe the current situation of the care for malignancy patients with hypogammaglobulinemia in China.<\/jats:p>\n            <jats:p>We adapted a previously published online questionnaire of current clinical practices regarding the management of secondary immunodeficiency caused by hematological malignancies and then distributed the questionnaire to 52 hematologists in China via WeChat mobile software; the survey collected demographic details, starting dosage, target immunoglobulin (Ig) level, monitoring, criteria for stopping Ig replacement, vaccination use, and oral antibiotic prophylaxis for hypogammaglobulinemia patients.<\/jats:p>\n            <jats:p>Forty-eight hematologists responded. 28(58.33%) respondents had more than 10 years of experience. Nevertheless, 40(83.33%) respondents reported that they did not use any specific criteria for prophylactic Ig replacement in hypogammaglobulinemia patients. However, 27(56.25%) respondents reported that they had used intravenous immunoglobulin (IVIG); however, the starting dose, frequency, and target Ig level were significantly varied. Additionally, the criteria for stopping Ig replacement were significantly varied. Only one respondent (2.08%) used subcutaneous immunoglobulin (SCIG). Moreover, 35(72.92%) respondents reported no vaccination prior to Ig replacement, and 47(97.92%) respondents reported that they had not used antibiotic prophylaxis in secondary hypogammaglobulinemia patients.<\/jats:p>\n            <jats:p>Official guideline for the care for secondary immunodeficiency (SID) of the hematological malignancies patients should be issued in China, and significant attention of the hematologists should be paid to the use of prophylactic antibiotics and Ig replacement for the care of patients with hypogammaglobulinemia caused by hematological malignancies, as these agents could significantly reduce the infection rate in China.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000023935","type":"journal-article","created":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T13:41:48Z","timestamp":1611409308000},"page":"e23935","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["A clinician survey for management of the secondary immunodeficiency caused by hematological malignancies in China"],"prefix":"10.1097","volume":"100","author":[{"given":"Chunmei","family":"Ye","sequence":"first","affiliation":[{"name":"College of Medical Technology, Zhejiang Chinese Medical University, 548 Bingwen Road, Hangzhou"},{"name":"Department of Clinical Laboratory, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, 158 Shangtang Road, Hangzhou"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Hematology, The 2nd Affiliated Hospital of Harbin Medical University, 246 Xuefu Road, Harbin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolu","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Hematology, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, 158 Shangtang Road, Hangzhou, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0416-4603","authenticated-orcid":false,"given":"Sujie","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, 158 Shangtang Road, Hangzhou"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinlin","family":"Liu","sequence":"additional","affiliation":[{"name":"College of Medical Technology, Zhejiang Chinese Medical University, 548 Bingwen Road, Hangzhou"},{"name":"Department of Clinical Laboratory, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, 158 Shangtang Road, Hangzhou"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,1,22]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/ejh.13223","article-title":"Current clinical practice and challenges in the management of secondary immunodeficiency in hematological malignancies","volume":"102","author":"Na","year":"2019","journal-title":"Eur J Haematol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/ejh.13078","article-title":"A French observational study describing the use of human polyvalent immunoglobulins in hematological malignancy-associated secondary immunodeficiency","volume":"101","author":"Benbrahim","year":"2018","journal-title":"Eur J Haematol"},{"issue":"(Suppl 2)","key":"R3-20250504","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1097\/01.all.0000433132.16436.b5","article-title":"Management of secondary immune deficiencies: what is the role of immunoglobulins?","volume":"13","author":"Mouthon","year":"2013","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2016.09.023","article-title":"Update on the use of immunoglobulin in human disease: a review of evidence","volume":"139","author":"Perez","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1542\/pir.2017-0308","article-title":"Immunodeficiency disorders","volume":"40","author":"Chinn","year":"2019","journal-title":"Pediatr Rev"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1182\/blood-2017-02-734541","article-title":"Diagnosis and classification of hematologic malignancies on the basis of genetics","volume":"130","author":"Taylor","year":"2017","journal-title":"Blood"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"977","DOI":"10.37358\/RC.19.3.7043","article-title":"The evaluation of oxidative stress and high-density lipoprotein cholesterol levels in diffuse large B-cell lymphoma","volume":"70","author":"Gaman","year":"2019","journal-title":"Rev Chim"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.25083\/rbl\/25.1\/1267.1274","article-title":"The involvement of oxidative stress in chronic myeloid leukemia","volume":"25","author":"Pascu","year":"2020","journal-title":"Rom Biotechnol Lett"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41375-018-0188-8","article-title":"Time resolved quantitative phospho-tyrosine analysis reveals Bruton's Tyrosine kinase mediated signaling downstream of the mutated granulocyte-colony stimulating factor receptors","volume":"33","author":"Dwivedi","year":"2019","journal-title":"Leukemia"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.clim.2017.11.014","article-title":"Subcutaneous immunoglobulins in patients with multiple myeloma and secondary hypogammaglobulinemia: a randomized trial","volume":"191","author":"Vacca","year":"2018","journal-title":"Clin Immunol (Orlando, FL)"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3389\/fimmu.2014.00629","article-title":"Is dosing of therapeutic immunoglobulins optimal? A review of a three-decade long debate in Europe","volume":"5","author":"Kerr","year":"2014","journal-title":"Front Immunol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.anai.2019.10.019","article-title":"Carbamazepine-induced B-cell aplasia: overlooked and overtreated","volume":"124","author":"Wong","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/imj.14082","article-title":"Managing hypogammaglobulinaemia secondary to haematological malignancies in Australia and New Zealand: a clinician survey","volume":"49","author":"Wong","year":"2019","journal-title":"Intern Med J"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/hon.2323","article-title":"Secondary immunodeficiency in lymphoproliferative malignancies","volume":"34","author":"Friman","year":"2016","journal-title":"Hematol Oncol"},{"key":"R19-20250504","first-page":"58","article-title":"Comparative study of clinical guidelines for intravenous immunoglobulin","volume":"35","author":"Zhang","year":"2016","journal-title":"Chin J New Drugs Clin Remedies"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.3324\/haematol.2014.117176","article-title":"European Myeloma Network guidelines for the management of multiple myeloma-related complications","volume":"100","author":"Terpos","year":"2015","journal-title":"Haematologica"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"v78","DOI":"10.1093\/annonc\/mdv303","article-title":"Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"26","author":"Eichhorst","year":"2015","journal-title":"Ann Oncol"},{"key":"R26-20250504","first-page":"3221","article-title":"European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia","volume":"73","author":"Maertens","year":"2018","journal-title":"J Antimicrob Chemother"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000023935","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T07:01:22Z","timestamp":1746342082000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000023935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,22]]},"references-count":18,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000023935","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2021,1,22]]},"assertion":[{"value":"2020-05-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}